NCCN Task Force report: Evaluating the clinical utility of tumor markers in oncology.

Febbo PG, Ladanyi M, Aldape KD, De Marzo AM, Hammond ME, Hayes DF, Iafrate AJ, Kelley RK, Marcucci G, Ogino S, Pao W, Sgroi DC, Birkeland ML
J Natl Compr Canc Netw. 2011 9 Suppl 5: S1-32; quiz S33

PMID: 22138009 · DOI:10.6004/jnccn.2011.0137

MeSH Terms (9)

Advisory Committees Biomarkers, Tumor Gene Expression Regulation, Neoplastic Genotype Humans Molecular Diagnostic Techniques Neoplasms Phenotype Prognosis

Connections (1)

This publication is referenced by other Labnodes entities: